ClinicalTrials.gg

Acute Kidney Injury clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 1,691 studies for Acute Kidney Injury across more than 10 countries. 393 are recruiting or about to start. 1,247 of them are mainly about Acute Kidney Injury (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17.

ClinicalTrials.gov finds 1,910 studies for Acute Kidney Injury. How that becomes 1,691 hereChecked on ClinicalTrials.gov . The studies here are updated every night.

This page counts the studies the registry files under Acute Kidney Injury, and those it files under no condition that list Acute Kidney Injurythemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. Only this comparison waits for its turn: it is asked again about once a week, so between two checks the registry's number can run a little ahead of it. How condition pages count

  1. 1,910Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −17List Acute Kidney Injury as a condition, but the registry did not file them under itMost often written as “Contrast-induced Acute Kidney Injury” (5), “Postoperative Acute Kidney Injury” (4), and “Acute Kidney Injury Due to Sepsis” (2). The registry filed them under other conditions only, most often Coronary Artery Disease (2) and ST Elevation Myocardial Infarction (2).
  3. −205Match it another way161 name it in the title, 11 in a keyword, and 33 by a synonym or other text the search reads.
  4. 1,688Counted here and found by its search66 of them list Acute Kidney Injury in their own words; the registry filed them under no condition.
  5. +3
    Counted here, but its search does not find them
  6. 1,691The count on this page

Status

Completed
851
Recruiting
230
Status unknown
228
Not yet recruiting
147
Terminated
101
Withdrawn
57

Phase

Phase 2
159
Phase 4
110
Phase 3
108
Phase 1
42
Early Phase 1
9

Where

United States
370
China
168
France
154
Germany
109
Turkey
90
Canada
83

Who develops what

Add Acute Kidney Injury to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 7 programs from 6 companies, 5 with this as their studies’ main aim; 1 with a live phase 3 study; 4 primary completions in the next 12 months. Compare AstraZeneca and CSL here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
TerlipressinRecent, limited
Evidence
  • NCT06256432 · Noorik Biopharmaceuticals AG · Phase 2 · live · comparator · “Terlipressin” · registered Feb 2024
Keenova Therapeutics plc50% of its industry studiesUS: Keenova Therapeutics plc (FDA 2022)11 study

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

In phase 3Company
QRX-3☆ Track2 live phase-3 studies: NCT07161843, NCT06866236Ebima Clifford Okundaye

The 1 in phase 3 with the nearest primary completion, of 7 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (4)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • 30 Dec 2026 est.QRX-3 · Ebima Clifford Okundaye · Phase 3 main aimNCT07161843 Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF) — primary endpoint: Rate of change in creatinine glomerular filtration rate · 500 enrolled
  • 11 Feb 2027 est.Berzanoflast · AstraZeneca · Phase 2 named, not the main aimNCT07215702 A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury. — primary endpoint: Area Under the Curve (AUC) of 24-hour Creatinine Clearance (CrCl). · 124 enrolled
  • 1 Apr 2027 est.R2R01 · River 2 Renal Corp. · Phase 2 main aimNCT07625553 Study of the Relaxin Agonist R2R01 in Patients at High Risk for Cardiac Surgery Associated- Acute Kidney Injury — primary endpoint: The safety and efficacy of R2R01 for prevention of AKI (Proportion of subjects deve) after cardiac surgery (CABG, valve surgery, aortic surgery, or a combination of the above) involving CPB, in subjects with additional risk factors for developing CSA-AKI · 430 enrolled

1 more — sign in to see them all, free.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Acute Kidney Injury studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here SGLT2 inhibitors 4 open · Phosphodiesterase inhibitors 2 open · Beta-lactamase inhibitors 2 open · Diuretics 1 open · Statins 1 open

Coming up

142studies finish main data collection within a year6 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 230 Acute Kidney Injury studies recruiting now, 162 (70%) set no upper age limit and 35 (15%) stop at 75 or younger. 22 (10%) take children under 18. 2 (1%) are for women only and 1 (<1%) for men only; 25 (11%) take healthy volunteers.

Recruiting studies that take each age, of 230
AgeWomenMen
1018 (8%)18 (8%)
18208 (90%)207 (90%)
30211 (92%)210 (91%)
40211 (92%)210 (91%)
50214 (93%)213 (93%)
65214 (93%)213 (93%)
75203 (88%)202 (88%)
85182 (79%)182 (79%)

Across all 1,691 studies, recruiting or not: 14% stop at 75 or younger and 10% at 65; 14% take children; 1% are for women only and 1% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Acute Kidney Injury studies take

Of 57 phase 2 interventional studies under Acute Kidney Injury, half reached primary completion within 29 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 229 mo16–42 · 57 studies—30 mo13–42 · 39 studies
Phase 333 mo14–63 · 35 studies——
Phase 430 mo14–57 · 46 studies—28 mo14–57 · 45 studies
Interventional, no phase26 mo12–44 · 268 studies—27 mo12–44 · 250 studies
Observational24 mo12–42 · 365 studies—24 mo12–42 · 350 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 19, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 1,691. Browse all 1,691 → or search them.